GuiZhou SanLi Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 376.980 million compared to CNY 281.919 million a year ago. Operating income was CNY 83.863 million compared to CNY 56.842 million a year ago. Net income was CNY 69.388 million compared to CNY 46.478 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.12 a year ago.